ID   CP2E1_HUMAN             Reviewed;         493 AA.
AC   P05181; Q5VZD5; Q6NWT9; Q9UK47;
DT   13-AUG-1987, integrated into UniProtKB/Swiss-Prot.
DT   01-APR-1988, sequence version 1.
DT   10-MAY-2017, entry version 185.
DE   RecName: Full=Cytochrome P450 2E1;
DE            EC=1.14.13.-;
DE   AltName: Full=4-nitrophenol 2-hydroxylase;
DE            EC=1.14.13.n7;
DE   AltName: Full=CYPIIE1;
DE   AltName: Full=Cytochrome P450-J;
DE   Contains:
DE     RecName: Full=Cytochrome P450 2E1, N-terminally processed;
GN   Name=CYP2E1; Synonyms=CYP2E;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RX   PubMed=3782137;
RA   Song B.-J., Gelboin H.V., Park S.-S., Yang C.S., Gonzalez F.J.;
RT   "Complementary DNA and protein sequences of ethanol-inducible rat and
RT   human cytochrome P-450s. Transcriptional and post-transcriptional
RT   regulation of the rat enzyme.";
RL   J. Biol. Chem. 261:16689-16697(1986).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA].
RX   PubMed=3233219; DOI=10.1021/bi00425a019;
RA   Umeno M., McBride O.W., Yang C.S., Gelboin H.V., Gonzalez F.J.;
RT   "Human ethanol-inducible P450IIE1: complete gene sequence, promoter
RT   characterization, chromosome mapping, and cDNA-directed expression.";
RL   Biochemistry 27:9006-9013(1988).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RC   TISSUE=Liver;
RA   Zhuge J., Qian Y., Xie H., Yu Y.;
RT   "Sequence of a new human cytochrome P450-2E1 cDNA and establishing the
RT   transgenic cell line.";
RL   Submitted (SEP-1999) to the EMBL/GenBank/DDBJ databases.
RN   [4]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA], AND VARIANTS ASP-219; CYS-366 AND
RP   LEU-457.
RG   NIEHS SNPs program;
RL   Submitted (APR-2006) to the EMBL/GenBank/DDBJ databases.
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=15164054; DOI=10.1038/nature02462;
RA   Deloukas P., Earthrowl M.E., Grafham D.V., Rubenfield M., French L.,
RA   Steward C.A., Sims S.K., Jones M.C., Searle S., Scott C., Howe K.,
RA   Hunt S.E., Andrews T.D., Gilbert J.G.R., Swarbreck D., Ashurst J.L.,
RA   Taylor A., Battles J., Bird C.P., Ainscough R., Almeida J.P.,
RA   Ashwell R.I.S., Ambrose K.D., Babbage A.K., Bagguley C.L., Bailey J.,
RA   Banerjee R., Bates K., Beasley H., Bray-Allen S., Brown A.J.,
RA   Brown J.Y., Burford D.C., Burrill W., Burton J., Cahill P., Camire D.,
RA   Carter N.P., Chapman J.C., Clark S.Y., Clarke G., Clee C.M., Clegg S.,
RA   Corby N., Coulson A., Dhami P., Dutta I., Dunn M., Faulkner L.,
RA   Frankish A., Frankland J.A., Garner P., Garnett J., Gribble S.,
RA   Griffiths C., Grocock R., Gustafson E., Hammond S., Harley J.L.,
RA   Hart E., Heath P.D., Ho T.P., Hopkins B., Horne J., Howden P.J.,
RA   Huckle E., Hynds C., Johnson C., Johnson D., Kana A., Kay M.,
RA   Kimberley A.M., Kershaw J.K., Kokkinaki M., Laird G.K., Lawlor S.,
RA   Lee H.M., Leongamornlert D.A., Laird G., Lloyd C., Lloyd D.M.,
RA   Loveland J., Lovell J., McLaren S., McLay K.E., McMurray A.,
RA   Mashreghi-Mohammadi M., Matthews L., Milne S., Nickerson T.,
RA   Nguyen M., Overton-Larty E., Palmer S.A., Pearce A.V., Peck A.I.,
RA   Pelan S., Phillimore B., Porter K., Rice C.M., Rogosin A., Ross M.T.,
RA   Sarafidou T., Sehra H.K., Shownkeen R., Skuce C.D., Smith M.,
RA   Standring L., Sycamore N., Tester J., Thorpe A., Torcasso W.,
RA   Tracey A., Tromans A., Tsolas J., Wall M., Walsh J., Wang H.,
RA   Weinstock K., West A.P., Willey D.L., Whitehead S.L., Wilming L.,
RA   Wray P.W., Young L., Chen Y., Lovering R.C., Moschonas N.K.,
RA   Siebert R., Fechtel K., Bentley D., Durbin R.M., Hubbard T.,
RA   Doucette-Stamm L., Beck S., Smith D.R., Rogers J.;
RT   "The DNA sequence and comparative analysis of human chromosome 10.";
RL   Nature 429:375-381(2004).
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (SEP-2005) to the EMBL/GenBank/DDBJ databases.
RN   [7]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [8]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 32-493.
RC   TISSUE=Brain;
RA   Yoo M., Shin S.W.;
RT   "Partial sequence of human brain cytochrome P450 2E1.";
RL   Submitted (AUG-1998) to the EMBL/GenBank/DDBJ databases.
RN   [9]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 387-432.
RA   Iwahashi K., Okuyama E., Nakamura K., Furukawa A., Ichikawa Y.;
RT   "Rapid detection of a novel mutation in the human CYP2EI exon VIII by
RT   the PCR method.";
RL   Submitted (APR-1995) to the EMBL/GenBank/DDBJ databases.
RN   [10]
RP   PROTEIN SEQUENCE OF 1-20.
RC   TISSUE=Liver;
RX   PubMed=3675576; DOI=10.1016/0006-291X(87)91100-4;
RA   Lasker J.M., Raucy J., Kubota S., Bloswick B.P., Black M.,
RA   Lieber C.S.;
RT   "Purification and characterization of human liver cytochrome P-450-
RT   ALC.";
RL   Biochem. Biophys. Res. Commun. 148:232-238(1987).
RN   [11]
RP   PROTEIN SEQUENCE OF 3-20.
RX   PubMed=2587619; DOI=10.1159/000138590;
RA   Robinson R.C., Shorr R.G., Varrichio A., Park S.S., Gelboin H.V.,
RA   Miller H., Friedman F.K.;
RT   "Human liver cytochrome P-450 related to a rat acetone-inducible,
RT   nitrosamine-metabolizing cytochrome P-450: identification and
RT   isolation.";
RL   Pharmacology 39:137-144(1989).
RN   [12]
RP   PROTEIN SEQUENCE OF 23-42.
RX   PubMed=8031147; DOI=10.1006/abbi.1994.1280;
RA   Gillam E.M., Guo Z., Guengerich F.P.;
RT   "Expression of modified human cytochrome P450 2E1 in Escherichia coli,
RT   purification, and spectral and catalytic properties.";
RL   Arch. Biochem. Biophys. 312:59-66(1994).
RN   [13]
RP   CATALYTIC ACTIVITY.
RX   PubMed=9348445; DOI=10.1021/tx970048z;
RA   Zerilli A., Ratanasavanh D., Lucas D., Goasduff T., Dreano Y.,
RA   Menard C., Picart D., Berthou F.;
RT   "Both cytochromes P450 2E1 and 3A are involved in the O-hydroxylation
RT   of p-nitrophenol, a catalytic activity known to be specific for P450
RT   2E1.";
RL   Chem. Res. Toxicol. 10:1205-1212(1997).
RN   [14]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Liver;
RX   PubMed=24275569; DOI=10.1016/j.jprot.2013.11.014;
RA   Bian Y., Song C., Cheng K., Dong M., Wang F., Huang J., Sun D.,
RA   Wang L., Ye M., Zou H.;
RT   "An enzyme assisted RP-RPLC approach for in-depth analysis of human
RT   liver phosphoproteome.";
RL   J. Proteomics 96:253-262(2014).
RN   [15]
RP   X-RAY CRYSTALLOGRAPHY (2.2 ANGSTROMS) OF 32-493 IN COMPLEX WITH THE
RP   INHIBITORS INDAZOLE AND 4-METHYLPYRAZOLE AND HEME.
RX   PubMed=18818195; DOI=10.1074/jbc.M805999200;
RA   Porubsky P.R., Meneely K.M., Scott E.E.;
RT   "Structures of human cytochrome P-450 2E1. Insights into the binding
RT   of inhibitors and both small molecular weight and fatty acid
RT   substrates.";
RL   J. Biol. Chem. 283:33698-33707(2008).
RN   [16]
RP   VARIANTS CYP2E1*2 HIS-76 AND CYP2E1*3 ILE-389.
RX   PubMed=9058590;
RA   Hu Y., Oscarson M., Johansson I., Yue Q.Y., Dahl M.L., Tabone M.,
RA   Arinco S., Albano E., Ingelman-Sundberg M.;
RT   "Genetic polymorphism of human CYP2E1: characterization of two variant
RT   alleles.";
RL   Mol. Pharmacol. 51:370-376(1997).
RN   [17]
RP   VARIANT CYP2E1*4 ILE-179.
RX   PubMed=9918138;
RA   Fairbrother K.S., Grove J., de Waziers I., Steimel D.T., Day C.P.,
RA   Crespi C.L., Daly A.K.;
RT   "Detection and characterization of novel polymorphisms in the CYP2E1
RT   gene.";
RL   Pharmacogenetics 8:543-552(1998).
RN   [18]
RP   VARIANTS ILE-179 AND LEU-457.
RX   PubMed=15469410; DOI=10.1517/14622416.5.7.895;
RA   Solus J.F., Arietta B.J., Harris J.R., Sexton D.P., Steward J.Q.,
RA   McMunn C., Ihrie P., Mehall J.M., Edwards T.L., Dawson E.P.;
RT   "Genetic variation in eleven phase I drug metabolism genes in an
RT   ethnically diverse population.";
RL   Pharmacogenomics 5:895-931(2004).
CC   -!- FUNCTION: Metabolizes several precarcinogens, drugs, and solvents
CC       to reactive metabolites. Inactivates a number of drugs and
CC       xenobiotics and also bioactivates many xenobiotic substrates to
CC       their hepatotoxic or carcinogenic forms.
CC   -!- CATALYTIC ACTIVITY: 4-nitrophenol + NADPH + O(2) = 4-nitrocatechol
CC       + NADP(+) + H(2)O. {ECO:0000269|PubMed:9348445}.
CC   -!- COFACTOR:
CC       Name=heme; Xref=ChEBI:CHEBI:30413;
CC   -!- SUBCELLULAR LOCATION: Endoplasmic reticulum membrane; Peripheral
CC       membrane protein. Microsome membrane; Peripheral membrane protein.
CC   -!- INDUCTION: By ethanol and isoniazid.
CC   -!- SIMILARITY: Belongs to the cytochrome P450 family. {ECO:0000305}.
CC   -!- WEB RESOURCE: Name=Cytochrome P450 Allele Nomenclature Committee;
CC       Note=CYP2E1 alleles;
CC       URL="http://www.cypalleles.ki.se/cyp2e1.htm";
CC   -!- WEB RESOURCE: Name=Wikipedia; Note=CYP2E1 entry;
CC       URL="https://en.wikipedia.org/wiki/CYP2E1";
CC   -!- WEB RESOURCE: Name=NIEHS-SNPs;
CC       URL="http://egp.gs.washington.edu/data/cyp2e1/";
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; J02625; AAA35743.1; -; mRNA.
DR   EMBL; J02843; AAA52155.1; -; Genomic_DNA.
DR   EMBL; AF182276; AAF13601.1; -; mRNA.
DR   EMBL; DQ515958; ABF47105.1; -; Genomic_DNA.
DR   EMBL; AL161645; CAH70047.1; -; Genomic_DNA.
DR   EMBL; CH471211; EAW61357.1; -; Genomic_DNA.
DR   EMBL; BC067433; AAH67433.1; -; mRNA.
DR   EMBL; AF084225; AAD13753.1; -; mRNA.
DR   EMBL; D50111; BAA08796.1; -; Genomic_DNA.
DR   CCDS; CCDS7686.1; -.
DR   PIR; A31949; A31949.
DR   RefSeq; NP_000764.1; NM_000773.3.
DR   UniGene; Hs.12907; -.
DR   PDB; 3E4E; X-ray; 2.60 A; A/B=32-493.
DR   PDB; 3E6I; X-ray; 2.20 A; A/B=32-493.
DR   PDB; 3GPH; X-ray; 2.70 A; A/B=32-493.
DR   PDB; 3KOH; X-ray; 2.90 A; A/B=32-493.
DR   PDB; 3LC4; X-ray; 3.10 A; A/B=32-493.
DR   PDB; 3T3Z; X-ray; 2.35 A; A/B/C/D=32-493.
DR   PDBsum; 3E4E; -.
DR   PDBsum; 3E6I; -.
DR   PDBsum; 3GPH; -.
DR   PDBsum; 3KOH; -.
DR   PDBsum; 3LC4; -.
DR   PDBsum; 3T3Z; -.
DR   ProteinModelPortal; P05181; -.
DR   SMR; P05181; -.
DR   BioGrid; 107944; 18.
DR   IntAct; P05181; 10.
DR   STRING; 9606.ENSP00000252945; -.
DR   BindingDB; P05181; -.
DR   ChEMBL; CHEMBL5281; -.
DR   DrugBank; DB00316; Acetaminophen.
DR   DrugBank; DB00041; Aldesleukin.
DR   DrugBank; DB00918; Almotriptan.
DR   DrugBank; DB00969; Alosetron.
DR   DrugBank; DB01223; Aminophylline.
DR   DrugBank; DB00321; Amitriptyline.
DR   DrugBank; DB06728; Aniline.
DR   DrugBank; DB01435; Antipyrine.
DR   DrugBank; DB00972; Azelastine.
DR   DrugBank; DB06770; Benzyl alcohol.
DR   DrugBank; DB04794; Bifonazole.
DR   DrugBank; DB01558; Bromazepam.
DR   DrugBank; DB00835; Brompheniramine.
DR   DrugBank; DB01156; Bupropion.
DR   DrugBank; DB00201; Caffeine.
DR   DrugBank; DB06774; Capsaicin.
DR   DrugBank; DB00748; Carbinoxamine.
DR   DrugBank; DB01136; Carvedilol.
DR   DrugBank; DB00477; Chlorpromazine.
DR   DrugBank; DB00356; Chlorzoxazone.
DR   DrugBank; DB00501; Cimetidine.
DR   DrugBank; DB00215; Citalopram.
DR   DrugBank; DB04920; Clevidipine.
DR   DrugBank; DB00636; Clofibrate.
DR   DrugBank; DB00882; Clomifene.
DR   DrugBank; DB01068; Clonazepam.
DR   DrugBank; DB00257; Clotrimazole.
DR   DrugBank; DB00363; Clozapine.
DR   DrugBank; DB01394; Colchicine.
DR   DrugBank; DB00851; Dacarbazine.
DR   DrugBank; DB06637; Dalfampridine.
DR   DrugBank; DB00250; Dapsone.
DR   DrugBank; DB01151; Desipramine.
DR   DrugBank; DB01234; Dexamethasone.
DR   DrugBank; DB01191; Dexfenfluramine.
DR   DrugBank; DB00633; Dexmedetomidine.
DR   DrugBank; DB00514; Dextromethorphan.
DR   DrugBank; DB00829; Diazepam.
DR   DrugBank; DB00586; Diclofenac.
DR   DrugBank; DB00255; Diethylstilbestrol.
DR   DrugBank; DB00822; Disulfiram.
DR   DrugBank; DB01127; Econazole.
DR   DrugBank; DB08846; Ellagic Acid.
DR   DrugBank; DB00228; Enflurane.
DR   DrugBank; DB00109; Enfuvirtide.
DR   DrugBank; DB00655; Estrone.
DR   DrugBank; DB00898; Ethanol.
DR   DrugBank; DB06689; Ethanolamine Oleate.
DR   DrugBank; DB00593; Ethosuximide.
DR   DrugBank; DB00773; Etoposide.
DR   DrugBank; DB01628; Etoricoxib.
DR   DrugBank; DB00949; Felbamate.
DR   DrugBank; DB08868; Fingolimod.
DR   DrugBank; DB01544; Flunitrazepam.
DR   DrugBank; DB00623; Fluphenazine.
DR   DrugBank; DB00690; Flurazepam.
DR   DrugBank; DB00176; Fluvoxamine.
DR   DrugBank; DB00158; Folic Acid.
DR   DrugBank; DB01213; Fomepizole.
DR   DrugBank; DB01296; Glucosamine.
DR   DrugBank; DB04077; Glycerol.
DR   DrugBank; DB05708; GTS-21.
DR   DrugBank; DB01159; Halothane.
DR   DrugBank; DB01355; Hexobarbital.
DR   DrugBank; DB04946; Iloperidone.
DR   DrugBank; DB00458; Imipramine.
DR   DrugBank; DB00753; Isoflurane.
DR   DrugBank; DB00951; Isoniazid.
DR   DrugBank; DB00883; Isosorbide Dinitrate.
DR   DrugBank; DB01167; Itraconazole.
DR   DrugBank; DB00170; Menadione.
DR   DrugBank; DB00371; Meprobamate.
DR   DrugBank; DB00703; Methazolamide.
DR   DrugBank; DB00763; Methimazole.
DR   DrugBank; DB01403; Methotrimeprazine.
DR   DrugBank; DB01028; Methoxyflurane.
DR   DrugBank; DB01011; Metyrapone.
DR   DrugBank; DB00379; Mexiletine.
DR   DrugBank; DB01110; Miconazole.
DR   DrugBank; DB00683; Midazolam.
DR   DrugBank; DB01204; Mitoxantrone.
DR   DrugBank; DB00622; Nicardipine.
DR   DrugBank; DB02701; Nicotinamide.
DR   DrugBank; DB00184; Nicotine.
DR   DrugBank; DB01115; Nifedipine.
DR   DrugBank; DB06712; Nilvadipine.
DR   DrugBank; DB01595; Nitrazepam.
DR   DrugBank; DB00540; Nortriptyline.
DR   DrugBank; DB00904; Ondansetron.
DR   DrugBank; DB01173; Orphenadrine.
DR   DrugBank; DB00526; Oxaliplatin.
DR   DrugBank; DB00617; Paramethadione.
DR   DrugBank; DB03783; Phenacetin.
DR   DrugBank; DB00780; Phenelzine.
DR   DrugBank; DB01174; Phenobarbital.
DR   DrugBank; DB01085; Pilocarpine.
DR   DrugBank; DB01100; Pimozide.
DR   DrugBank; DB04977; Plitidepsin.
DR   DrugBank; DB01131; Proguanil.
DR   DrugBank; DB00818; Propofol.
DR   DrugBank; DB00908; Quinidine.
DR   DrugBank; DB00468; Quinine.
DR   DrugBank; DB01045; Rifampicin.
DR   DrugBank; DB00503; Ritonavir.
DR   DrugBank; DB06201; Rufinamide.
DR   DrugBank; DB00118; S-Adenosylmethionine.
DR   DrugBank; DB01037; Selegiline.
DR   DrugBank; DB01236; Sevoflurane.
DR   DrugBank; DB00203; Sildenafil.
DR   DrugBank; DB00428; Streptozocin.
DR   DrugBank; DB00359; Sulfadiazine.
DR   DrugBank; DB00259; Sulfanilamide.
DR   DrugBank; DB00675; Tamoxifen.
DR   DrugBank; DB01079; Tegaserod.
DR   DrugBank; DB01041; Thalidomide.
DR   DrugBank; DB01412; Theobromine.
DR   DrugBank; DB00277; Theophylline.
DR   DrugBank; DB00599; Thiopental.
DR   DrugBank; DB00679; Thioridazine.
DR   DrugBank; DB00208; Ticlopidine.
DR   DrugBank; DB01007; Tioconazole.
DR   DrugBank; DB04858; Tirapazamine.
DR   DrugBank; DB05109; Trabectedin.
DR   DrugBank; DB00752; Tranylcypromine.
DR   DrugBank; DB00347; Trimethadione.
DR   DrugBank; DB01586; Ursodeoxycholic acid.
DR   DrugBank; DB00549; Zafirlukast.
DR   DrugBank; DB01198; Zopiclone.
DR   GuidetoPHARMACOLOGY; 1330; -.
DR   SwissLipids; SLP:000001596; -.
DR   iPTMnet; P05181; -.
DR   PhosphoSitePlus; P05181; -.
DR   BioMuta; CYP2E1; -.
DR   DMDM; 117250; -.
DR   PaxDb; P05181; -.
DR   PeptideAtlas; P05181; -.
DR   PRIDE; P05181; -.
DR   Ensembl; ENST00000252945; ENSP00000252945; ENSG00000130649.
DR   Ensembl; ENST00000463117; ENSP00000440689; ENSG00000130649.
DR   GeneID; 1571; -.
DR   KEGG; hsa:1571; -.
DR   UCSC; uc001lnj.1; human.
DR   CTD; 1571; -.
DR   DisGeNET; 1571; -.
DR   GeneCards; CYP2E1; -.
DR   HGNC; HGNC:2631; CYP2E1.
DR   HPA; HPA009128; -.
DR   HPA; HPA029564; -.
DR   MIM; 124040; gene.
DR   neXtProt; NX_P05181; -.
DR   OpenTargets; ENSG00000130649; -.
DR   PharmGKB; PA129; -.
DR   eggNOG; KOG0156; Eukaryota.
DR   eggNOG; COG2124; LUCA.
DR   GeneTree; ENSGT00760000118775; -.
DR   HOGENOM; HOG000036992; -.
DR   HOVERGEN; HBG015789; -.
DR   InParanoid; P05181; -.
DR   KO; K07415; -.
DR   OMA; GCIPPRY; -.
DR   OrthoDB; EOG091G0BT8; -.
DR   PhylomeDB; P05181; -.
DR   TreeFam; TF352043; -.
DR   BioCyc; MetaCyc:HS05414-MONOMER; -.
DR   Reactome; R-HSA-211981; Xenobiotics.
DR   Reactome; R-HSA-211999; CYP2E1 reactions.
DR   SABIO-RK; P05181; -.
DR   SIGNOR; P05181; -.
DR   EvolutionaryTrace; P05181; -.
DR   GeneWiki; CYP2E1; -.
DR   GenomeRNAi; 1571; -.
DR   PRO; PR:P05181; -.
DR   Proteomes; UP000005640; Chromosome 10.
DR   Bgee; ENSG00000130649; -.
DR   CleanEx; HS_CYP2E1; -.
DR   ExpressionAtlas; P05181; baseline and differential.
DR   Genevisible; P05181; HS.
DR   GO; GO:0005789; C:endoplasmic reticulum membrane; TAS:Reactome.
DR   GO; GO:0000139; C:Golgi membrane; IEA:Ensembl.
DR   GO; GO:0031227; C:intrinsic component of endoplasmic reticulum membrane; IEA:Ensembl.
DR   GO; GO:0005739; C:mitochondrion; IEA:Ensembl.
DR   GO; GO:0008392; F:arachidonic acid epoxygenase activity; IBA:GO_Central.
DR   GO; GO:0019899; F:enzyme binding; IPI:BHF-UCL.
DR   GO; GO:0020037; F:heme binding; IDA:UniProtKB.
DR   GO; GO:0005506; F:iron ion binding; IEA:InterPro.
DR   GO; GO:0004497; F:monooxygenase activity; IDA:BHF-UCL.
DR   GO; GO:0016491; F:oxidoreductase activity; IDA:BHF-UCL.
DR   GO; GO:0016709; F:oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, NAD(P)H as one donor, and incorporation of one atom of oxygen; TAS:UniProtKB.
DR   GO; GO:0016712; F:oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygen; IEA:Ensembl.
DR   GO; GO:0019825; F:oxygen binding; TAS:Reactome.
DR   GO; GO:0018910; P:benzene metabolic process; TAS:Reactome.
DR   GO; GO:0018885; P:carbon tetrachloride metabolic process; TAS:Reactome.
DR   GO; GO:0017144; P:drug metabolic process; IDA:BHF-UCL.
DR   GO; GO:0019373; P:epoxygenase P450 pathway; IBA:GO_Central.
DR   GO; GO:0042197; P:halogenated hydrocarbon metabolic process; TAS:Reactome.
DR   GO; GO:0046483; P:heterocycle metabolic process; IDA:BHF-UCL.
DR   GO; GO:0016098; P:monoterpenoid metabolic process; IDA:BHF-UCL.
DR   GO; GO:0055114; P:oxidation-reduction process; IDA:BHF-UCL.
DR   GO; GO:0042493; P:response to drug; IEA:Ensembl.
DR   GO; GO:0045471; P:response to ethanol; IEA:Ensembl.
DR   GO; GO:0010243; P:response to organonitrogen compound; IEA:Ensembl.
DR   GO; GO:0010193; P:response to ozone; IEA:Ensembl.
DR   GO; GO:0008202; P:steroid metabolic process; IMP:BHF-UCL.
DR   GO; GO:0006641; P:triglyceride metabolic process; IEA:Ensembl.
DR   GO; GO:0006805; P:xenobiotic metabolic process; TAS:Reactome.
DR   InterPro; IPR001128; Cyt_P450.
DR   InterPro; IPR017972; Cyt_P450_CS.
DR   InterPro; IPR002401; Cyt_P450_E_grp-I.
DR   InterPro; IPR008070; Cyt_P450_E_grp-I_CYP2E-like.
DR   Pfam; PF00067; p450; 1.
DR   PRINTS; PR00463; EP450I.
DR   PRINTS; PR01687; EP450ICYP2E.
DR   PRINTS; PR00385; P450.
DR   SUPFAM; SSF48264; SSF48264; 1.
DR   PROSITE; PS00086; CYTOCHROME_P450; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Complete proteome; Direct protein sequencing;
KW   Endoplasmic reticulum; Heme; Iron; Membrane; Metal-binding; Microsome;
KW   Monooxygenase; NADP; Oxidoreductase; Polymorphism; Reference proteome.
FT   CHAIN         1    493       Cytochrome P450 2E1.
FT                                /FTId=PRO_0000051751.
FT   INIT_MET      1      1       Removed; alternate.
FT                                {ECO:0000250|UniProtKB:P05182}.
FT   CHAIN         2    493       Cytochrome P450 2E1, N-terminally
FT                                processed.
FT                                /FTId=PRO_0000434347.
FT   REGION      298    303       Substrate binding. {ECO:0000305}.
FT   METAL       437    437       Iron (heme axial ligand).
FT   VARIANT      76     76       R -> H (in allele CYP2E1*2; reduced
FT                                activity; dbSNP:rs72559710).
FT                                {ECO:0000269|PubMed:9058590}.
FT                                /FTId=VAR_008360.
FT   VARIANT     179    179       V -> I (in allele CYP2E1*4;
FT                                dbSNP:rs6413419).
FT                                {ECO:0000269|PubMed:15469410,
FT                                ECO:0000269|PubMed:9918138}.
FT                                /FTId=VAR_008361.
FT   VARIANT     219    219       N -> D (in dbSNP:rs41299426).
FT                                {ECO:0000269|Ref.4}.
FT                                /FTId=VAR_055382.
FT   VARIANT     366    366       S -> C (in dbSNP:rs41299434).
FT                                {ECO:0000269|Ref.4}.
FT                                /FTId=VAR_055383.
FT   VARIANT     389    389       V -> I (in allele CYP2E1*3;
FT                                dbSNP:rs55897648).
FT                                {ECO:0000269|PubMed:9058590}.
FT                                /FTId=VAR_008362.
FT   VARIANT     457    457       H -> L (in dbSNP:rs28969387).
FT                                {ECO:0000269|PubMed:15469410,
FT                                ECO:0000269|Ref.4}.
FT                                /FTId=VAR_024727.
FT   CONFLICT      2      2       Missing (in Ref. 10; AA sequence).
FT                                {ECO:0000305}.
FT   CONFLICT     23     23       W -> A (in Ref. 12; AA sequence).
FT                                {ECO:0000305}.
FT   CONFLICT     32     32       L -> N (in Ref. 12; AA sequence).
FT                                {ECO:0000305}.
FT   CONFLICT     71     71       Y -> C (in Ref. 7; AAH67433).
FT                                {ECO:0000305}.
FT   CONFLICT    235    235       V -> A (in Ref. 3; AAF13601).
FT                                {ECO:0000305}.
FT   CONFLICT    355    355       H -> R (in Ref. 7; AAH67433).
FT                                {ECO:0000305}.
FT   TURN         40     42       {ECO:0000244|PDB:3E6I}.
FT   HELIX        45     47       {ECO:0000244|PDB:3E6I}.
FT   HELIX        50     52       {ECO:0000244|PDB:3T3Z}.
FT   HELIX        53     64       {ECO:0000244|PDB:3E6I}.
FT   STRAND       66     72       {ECO:0000244|PDB:3E6I}.
FT   STRAND       75     80       {ECO:0000244|PDB:3E6I}.
FT   HELIX        83     91       {ECO:0000244|PDB:3E6I}.
FT   TURN         94     97       {ECO:0000244|PDB:3E6I}.
FT   HELIX       104    109       {ECO:0000244|PDB:3E6I}.
FT   STRAND      112    114       {ECO:0000244|PDB:3E6I}.
FT   HELIX       122    135       {ECO:0000244|PDB:3E6I}.
FT   HELIX       142    159       {ECO:0000244|PDB:3E6I}.
FT   TURN        160    163       {ECO:0000244|PDB:3E6I}.
FT   HELIX       169    172       {ECO:0000244|PDB:3E6I}.
FT   HELIX       174    185       {ECO:0000244|PDB:3E6I}.
FT   HELIX       194    209       {ECO:0000244|PDB:3E6I}.
FT   HELIX       213    220       {ECO:0000244|PDB:3E6I}.
FT   HELIX       222    225       {ECO:0000244|PDB:3E6I}.
FT   STRAND      228    230       {ECO:0000244|PDB:3T3Z}.
FT   HELIX       231    255       {ECO:0000244|PDB:3E6I}.
FT   STRAND      259    261       {ECO:0000244|PDB:3KOH}.
FT   HELIX       265    274       {ECO:0000244|PDB:3E6I}.
FT   STRAND      275    278       {ECO:0000244|PDB:3E6I}.
FT   STRAND      279    281       {ECO:0000244|PDB:3T3Z}.
FT   HELIX       286    317       {ECO:0000244|PDB:3E6I}.
FT   HELIX       319    332       {ECO:0000244|PDB:3E6I}.
FT   TURN        333    336       {ECO:0000244|PDB:3E6I}.
FT   HELIX       341    346       {ECO:0000244|PDB:3E6I}.
FT   HELIX       348    361       {ECO:0000244|PDB:3E6I}.
FT   STRAND      376    378       {ECO:0000244|PDB:3E6I}.
FT   STRAND      381    383       {ECO:0000244|PDB:3E6I}.
FT   STRAND      388    391       {ECO:0000244|PDB:3E6I}.
FT   HELIX       394    397       {ECO:0000244|PDB:3E6I}.
FT   TURN        400    402       {ECO:0000244|PDB:3E6I}.
FT   STRAND      403    405       {ECO:0000244|PDB:3E6I}.
FT   HELIX       411    414       {ECO:0000244|PDB:3E6I}.
FT   STRAND      419    421       {ECO:0000244|PDB:3E6I}.
FT   HELIX       433    435       {ECO:0000244|PDB:3LC4}.
FT   HELIX       440    457       {ECO:0000244|PDB:3E6I}.
FT   STRAND      458    464       {ECO:0000244|PDB:3E6I}.
FT   TURN        466    468       {ECO:0000244|PDB:3E6I}.
FT   STRAND      474    481       {ECO:0000244|PDB:3E6I}.
FT   STRAND      487    491       {ECO:0000244|PDB:3E6I}.
SQ   SEQUENCE   493 AA;  56849 MW;  ED0399E32A005644 CRC64;
     MSALGVTVAL LVWAAFLLLV SMWRQVHSSW NLPPGPFPLP IIGNLFQLEL KNIPKSFTRL
     AQRFGPVFTL YVGSQRMVVM HGYKAVKEAL LDYKDEFSGR GDLPAFHAHR DRGIIFNNGP
     TWKDIRRFSL TTLRNYGMGK QGNESRIQRE AHFLLEALRK TQGQPFDPTF LIGCAPCNVI
     ADILFRKHFD YNDEKFLRLM YLFNENFHLL STPWLQLYNN FPSFLHYLPG SHRKVIKNVA
     EVKEYVSERV KEHHQSLDPN CPRDLTDCLL VEMEKEKHSA ERLYTMDGIT VTVADLFFAG
     TETTSTTLRY GLLILMKYPE IEEKLHEEID RVIGPSRIPA IKDRQEMPYM DAVVHEIQRF
     ITLVPSNLPH EATRDTIFRG YLIPKGTVVV PTLDSVLYDN QEFPDPEKFK PEHFLNENGK
     FKYSDYFKPF STGKRVCAGE GLARMELFLL LCAILQHFNL KPLVDPKDID LSPIHIGFGC
     IPPRYKLCVI PRS
//
